Cargando…

Access to benznidazole for Chagas disease in the United States—Cautious optimism?

Drugs for neglected tropical diseases (NTD) are being excessively priced in the United States. Benznidazole, the first-line drug for Chagas disease, may become approved by the Food and Drug Administration (FDA) and manufactured by a private company in the US, thus placing it at risk of similar prici...

Descripción completa

Detalles Bibliográficos
Autores principales: Alpern, Jonathan D., Lopez-Velez, Rogelio, Stauffer, William M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598921/
https://www.ncbi.nlm.nih.gov/pubmed/28910299
http://dx.doi.org/10.1371/journal.pntd.0005794